{"name":"Oncomatryx Biopharma S.L.","slug":"oncomatryx-biopharma-s-l","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPZUFoaUZKU194NV9tZ2tyS2ZuNFktZmRXbTN1WE13dkZsR2RXRlBkQnlwSVptWmpfRDl0aUdBSVdOQUxNRi1xV0doVlp1djJadnZQTktlcDdkRENpb0hVZkJZU3pOLUF0TlZQNG9pS1piWkdlczZ3c0xSbEFoakF3WkxacVpFLWloQ21qNm4zdHUxeXhCcms5ekNKdXBpU1A0VjVCS01qR0g0SGFaaVhFdW40V0xkdkpZZndNR3RB?oc=5","date":"2025-07-16","type":"pipeline","source":"European Biotechnology Magazine","summary":"Oncomatryx Secures EU Funding to Advance Antibody-Drug Conjugate Platform - European Biotechnology Magazine","headline":"Oncomatryx Secures EU Funding to Advance Antibody-Drug Conjugate Platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxNNUtWRXlYZkNVY01GVm9oOFJEeVJjQ3d3Y0VCZDk2RjBBdHFzX2wxZHlzc0RZM1M0U09wekNEZ1FiLXVZUGVoQlRGbUdIMEdadllUWi05UTZiU1kwdlpDSEdINW1YSU0zdUROMnh3M2lmeHdFSEIzelZiSkQ2aENROVpLbEVYaXZicjI1QllYcFphWmJBTmowZWFjUzEyZDR1U0VtX3pvcUJFSkNsOGp5QnRLLWhPYXcxY3VtLUs5T0tHV3FPSEh6U2k5ZmRDelNoNkxHLWdXcUJxLU1NaU9ZX05ta2p3VFVmWlQ2LWxKaEVUMzFk?oc=5","date":"2025-07-15","type":"pipeline","source":"Business Wire","summary":"Oncomatryx Biopharma Awarded €12.5 Million EIC Accelerator Funding to Advance Groundbreaking ADCs - Business Wire","headline":"Oncomatryx Biopharma Awarded €12.5 Million EIC Accelerator Funding to Advance Groundbreaking ADCs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}